209 related articles for article (PubMed ID: 20164562)
1. Expression of Somatostatin, cortistatin, and their receptors, as well as dopamine receptors, but not of neprilysin, are reduced in the temporal lobe of Alzheimer's disease patients.
Gahete MD; Rubio A; Durán-Prado M; Avila J; Luque RM; Castaño JP
J Alzheimers Dis; 2010; 20(2):465-75. PubMed ID: 20164562
[TBL] [Abstract][Full Text] [Related]
2. RT-PCR and immunocytochemistry studies support the presence of somatostatin, cortistatin and somatostatin receptor subtypes in rat Kupffer cells.
Xidakis C; Mastrodimou N; Notas G; Renieri E; Kolios G; Kouroumalis E; Thermos K
Regul Pept; 2007 Oct; 143(1-3):76-82. PubMed ID: 17481746
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin and Alzheimer's disease.
Burgos-Ramos E; Hervás-Aguilar A; Aguado-Llera D; Puebla-Jiménez L; Hernández-Pinto AM; Barrios V; Arilla-Ferreiro E
Mol Cell Endocrinol; 2008 May; 286(1-2):104-11. PubMed ID: 18359553
[TBL] [Abstract][Full Text] [Related]
4. Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimer's disease patients.
Gahete MD; Rubio A; Córdoba-Chacón J; Gracia-Navarro F; Kineman RD; Avila J; Luque RM; Castaño JP
J Alzheimers Dis; 2010; 22(3):819-28. PubMed ID: 20858966
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin, tau, and beta-amyloid within the anterior olfactory nucleus in Alzheimer disease.
Saiz-Sanchez D; Ubeda-Bañon I; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Insausti R; Martinez-Marcos A
Exp Neurol; 2010 Jun; 223(2):347-50. PubMed ID: 19559700
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.
Hellström-Lindahl E; Ravid R; Nordberg A
Neurobiol Aging; 2008 Feb; 29(2):210-21. PubMed ID: 17098332
[TBL] [Abstract][Full Text] [Related]
7. Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors.
Notas G; Kolios G; Mastrodimou N; Kampa M; Vasilaki A; Xidakis C; Castanas E; Thermos K; Kouroumalis E
J Hepatol; 2004 May; 40(5):792-8. PubMed ID: 15094227
[TBL] [Abstract][Full Text] [Related]
8. Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.
Aisa B; Gil-Bea FJ; Solas M; García-Alloza M; Chen CP; Lai MK; Francis PT; Ramírez MJ
J Alzheimers Dis; 2010; 20(2):659-68. PubMed ID: 20164549
[TBL] [Abstract][Full Text] [Related]
9. Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide.
Hama E; Saido TC
Med Hypotheses; 2005; 65(3):498-500. PubMed ID: 15921860
[TBL] [Abstract][Full Text] [Related]
10. Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissues.
Dalm VA; Van Hagen PM; de Krijger RR; Kros JM; Van Koetsveld PM; Van Der Lely AJ; Lamberts SW; Hofland LJ
Clin Endocrinol (Oxf); 2004 May; 60(5):625-9. PubMed ID: 15104567
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of amyloid-beta peptide and Alzheimer's disease.
Iwata N; Higuchi M; Saido TC
Pharmacol Ther; 2005 Nov; 108(2):129-48. PubMed ID: 16112736
[TBL] [Abstract][Full Text] [Related]
12. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
van de Nes JA; Konermann S; Nafe R; Swaab DF
Acta Neuropathol; 2006 Feb; 111(2):126-38. PubMed ID: 16456666
[TBL] [Abstract][Full Text] [Related]
13. Methylation analysis of SST and SSTR4 promoters in the neocortex of Alzheimer's disease patients.
Grosser C; Neumann L; Horsthemke B; Zeschnigk M; van de Nes J
Neurosci Lett; 2014 Apr; 566():241-6. PubMed ID: 24602981
[TBL] [Abstract][Full Text] [Related]
14. Effect of cortistatin on tau phosphorylation at Ser262 site.
Rubio A; Pérez M; de Lecea L; Avila J
J Neurosci Res; 2008 Aug; 86(11):2462-75. PubMed ID: 18438934
[TBL] [Abstract][Full Text] [Related]
15. Identification of the receptors for somatostatin (SST) and cortistatin (CST) in chickens and investigation of the roles of cSST28, cSST14, and cCST14 in inhibiting cGHRH1-27NH2-induced growth hormone secretion in cultured chicken pituitary cells.
Meng F; Huang G; Gao S; Li J; Yan Z; Wang Y
Mol Cell Endocrinol; 2014 Mar; 384(1-2):83-95. PubMed ID: 24418361
[TBL] [Abstract][Full Text] [Related]
16. Brain site-specific gene expression analysis in Alzheimer's disease patients.
Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin, Alzheimer's disease and cognition: an old story coming of age?
Epelbaum J; Guillou JL; Gastambide F; Hoyer D; Duron E; Viollet C
Prog Neurobiol; 2009 Oct; 89(2):153-61. PubMed ID: 19595735
[TBL] [Abstract][Full Text] [Related]
18. Neprylisin decreases uniformly in Alzheimer's disease and in normal aging.
Russo R; Borghi R; Markesbery W; Tabaton M; Piccini A
FEBS Lett; 2005 Nov; 579(27):6027-30. PubMed ID: 16226260
[TBL] [Abstract][Full Text] [Related]
19. Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains.
Zhou XW; Li X; Bjorkdahl C; Sjogren MJ; Alafuzoff I; Soininen H; Grundke-Iqbal I; Iqbal K; Winblad B; Pei JJ
Neurobiol Dis; 2006 Jun; 22(3):657-68. PubMed ID: 16513361
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of somatostatin (SST) receptor type 5 (SSTR5) is associated with sexually dimorphic changes in the expression of SST and SST receptors in brain and pancreas.
Ramírez JL; Grant M; Norman M; Wang XP; Moldovan S; de Mayo FJ; Brunicardi C; Kumar U
Mol Cell Endocrinol; 2004 Jun; 221(1-2):105-19. PubMed ID: 15223137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
